BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34538258)

  • 1. Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia.
    Thompson KP; Nelson J; Kim H; Weinsheimer SM; Marchuk DA; Lawton MT; Krings T; Faughnan ME;
    Orphanet J Rare Dis; 2021 Sep; 16(1):390. PubMed ID: 34538258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mortality in patients with hereditary hemorrhagic telangiectasia.
    Thompson KP; Nelson J; Kim H; Pawlikowska L; Marchuk DA; Lawton MT; Faughnan ME;
    Orphanet J Rare Dis; 2021 Jan; 16(1):12. PubMed ID: 33407668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Kim H; Faughnan ME;
    Mol Genet Genomic Med; 2018 May; 6(3):350-356. PubMed ID: 29932521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.
    Nishida T; Faughnan ME; Krings T; Chakinala M; Gossage JR; Young WL; Kim H; Pourmohamad T; Henderson KJ; Schrum SD; James M; Quinnine N; Bharatha A; Terbrugge KG; White RI
    Am J Med Genet A; 2012 Nov; 158A(11):2829-34. PubMed ID: 22991266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia.
    Beslow LA; Krings T; Kim H; Hetts SW; Lawton MT; Ratjen F; Whitehead KJ; Gossage JR; McCulloch CE; Clancy M; Bagheri N; Faughnan ME;
    Pediatr Neurol; 2024 Jun; 155():120-125. PubMed ID: 38631080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
    Meybodi AT; Kim H; Nelson J; Hetts SW; Krings T; terBrugge KG; Faughnan ME; Lawton MT;
    Neurosurgery; 2018 Jan; 82(1):35-47. PubMed ID: 28973426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
    Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-Phenotype Correlations in Children with HHT.
    Kilian A; Latino GA; White AJ; Clark D; Chakinala MM; Ratjen F; McDonald J; Whitehead K; Gossage JR; Lin D; Henderson K; Pollak J; McWilliams JP; Kim H; Lawton MT; Faughnan ME;
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32842615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
    Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
    Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Risk of Intracranial Arteriovenous Malformation Hemorrhage in Patients With Hereditary Hemorrhagic Telangiectasia.
    Yang W; Liu A; Hung AL; Braileanu M; Wang JY; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    Neurosurgery; 2016 May; 78(5):684-93. PubMed ID: 26540357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
    Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
    Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia.
    Maher CO; Piepgras DG; Brown RD; Friedman JA; Pollock BE
    Stroke; 2001 Apr; 32(4):877-82. PubMed ID: 11283386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT.
    Kilian A; Latino GA; White AJ; Ratjen F; McDonald J; Whitehead KJ; Gossage JR; Krings T; Lawton MT; Kim H; Faughnan ME; The Brain Vascular Malformation Consortium Hht Investigator Group
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system.
    Simon M; Franke D; Ludwig M; Aliashkevich AF; Köster G; Oldenburg J; Boström A; Ziegler A; Schramm J
    J Neurosurg; 2006 Jun; 104(6):945-9. PubMed ID: 16776339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
    Mu W; Cordner ZA; Yuqi Wang K; Reed K; Robinson G; Mitchell S; Lin D
    Genet Med; 2018 Jun; 20(6):639-644. PubMed ID: 29048420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.